SB5 (BIIB606)- adalimumab-bwwd injection, solution

SB5 (BIIB606) by

Drug Labeling and Warnings

SB5 (BIIB606) by is a Prescription medication manufactured, distributed, or labeled by Catalent Indiana, LLC. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

SB5 (BIIB606) 
adalimumab-bwwd injection, solution

Product Information
Product Type	HUMAN PRESCRIPTION DRUG	Item Code (Source)	NDC: 61434-005
Route of Administration	INTRAVENOUS

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
ADALIMUMAB-BWWD (UNII: FYS6T7F842) (ADALIMUMAB - UNII:FYS6T7F842)	ADALIMUMAB-BWWD	40 mg  in 0.8 mL

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 61434-005-00	1280 in 1 CASE	08/27/2017
1		0.8 mL in 1 SYRINGE, GLASS; Type 3: Prefilled Biologic Delivery Device/System (syringe, patch, etc.)

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
export only		08/27/2017

Labeler - Catalent Indiana, LLC (172209277)